What we're reading, December 5, 2016: insurers may be turning a corner with Obamacare plans; selling insurance across state lines may be a difficult initiative to implement; and older Americans are not diligent about getting vaccinations.
Many big health insurers had been vocal about their losses on the Affordable Care Act (ACA) exchanges, but they may have turned a corner. According to USA TODAY, Blue Cross Blue Shield of North Carolina made nearly $400 in the first 3 quarters of 2016, which is about the amount it lost during the first 2 years of the ACA. Aetna will be leaving the exchanges in most states because of losses of more than $430 million since January 2014, despite making nearly $12 million in Texas, alone.
Selling insurance across state lines is one of President-elect Donald J. Trump’s few healthcare initiatives, but achieving that goal may not be easy. The plan is a favorite of Republicans, and Trump’s pick to lead HHS is a proponent of the idea, but state insurance regulators and industry officials are pushing back, reported The Wall Street Journal. The problem is that insurance regulation differs from state to state, and state officials argue such a proposal would go against Trump’s pledge to increase the power of the states and reduce the power of the federal government.
As they grow older, people are not as diligent about getting themselves vaccinated for diseases like influenza, pneumonia, and shingles. Less than two-thirds of Americans older than age 65 get the annual flu shot or pneumococcal vaccination. Uptake of the shingles vaccine is even worse, according to The New York Times. While the shingles vaccine was approved a decade ago and is recommended for people over the age of 60, only 31% of individuals older than 65 had received it in 2014.
Disparities in Telehealth Access Undermine Adoption Among Patients With Schizophrenia
January 16th 2025The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant racial and ethnic disparities in access to this technology among Medicaid beneficiaries with schizophrenia.
Read More
Study Suggests Postdischarge Care Needs Targeted, Multifaceted Approaches
January 15th 2025The findings challenge the effectiveness of these widely used transitional care interventions and suggest a need for more targeted, multifaceted approaches to address the needs of higher-risk patients.
Read More
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
December 19th 2024Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
Listen